000 | 01984 a2200601 4500 | ||
---|---|---|---|
005 | 20250518093016.0 | ||
264 | 0 | _c20200401 | |
008 | 202004s 0 0 eng d | ||
022 | _a1533-4406 | ||
024 | 7 |
_a10.1056/NEJMoa1902493 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKozal, Michael | |
245 | 0 | 0 |
_aFostemsavir in Adults with Multidrug-Resistant HIV-1 Infection. _h[electronic resource] |
260 |
_bThe New England journal of medicine _c03 2020 |
||
300 |
_a1232-1243 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAnti-Retroviral Agents _xtherapeutic use |
650 | 0 | 4 | _aCD4 Lymphocyte Count |
650 | 0 | 4 | _aDrug Resistance, Multiple, Viral |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
650 | 0 | 4 |
_aHIV-1 _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOrganophosphates _xtherapeutic use |
650 | 0 | 4 |
_aPiperazines _xtherapeutic use |
650 | 0 | 4 |
_aProdrugs _xtherapeutic use |
650 | 0 | 4 |
_aRNA, Viral _xblood |
650 | 0 | 4 |
_aViral Load _xdrug effects |
700 | 1 | _aAberg, Judith | |
700 | 1 | _aPialoux, Gilles | |
700 | 1 | _aCahn, Pedro | |
700 | 1 | _aThompson, Melanie | |
700 | 1 | _aMolina, Jean-Michel | |
700 | 1 | _aGrinsztejn, Beatriz | |
700 | 1 | _aDiaz, Ricardo | |
700 | 1 | _aCastagna, Antonella | |
700 | 1 | _aKumar, Princy | |
700 | 1 | _aLatiff, Gulam | |
700 | 1 | _aDeJesus, Edwin | |
700 | 1 | _aGummel, Mark | |
700 | 1 | _aGartland, Margaret | |
700 | 1 | _aPierce, Amy | |
700 | 1 | _aAckerman, Peter | |
700 | 1 | _aLlamoso, Cyril | |
700 | 1 | _aLataillade, Max | |
773 | 0 |
_tThe New England journal of medicine _gvol. 382 _gno. 13 _gp. 1232-1243 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJMoa1902493 _zAvailable from publisher's website |
999 |
_c30780601 _d30780601 |